Skip to content

ENAVATE SCIENCES GP, LLC: IMNM position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ENAVATE SCIENCES GP, LLC on IMNM, newest first. How the timeline and the estimate are built.

ENAVATE SCIENCES GP, LLC held 3,613,799 IMNM shares at 2026-06-30 per its 13F-HR filed 2026-08-14.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 3,613,799 shares
    Change vs previous 13F 0 shares

    22.17% of the 13F portfolio, value $76,576,401.

    13F-HR 0001953107-26-000012 filed by ENAVATE SCIENCES GP, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 3,613,799 shares
    Change vs previous 13F -1,154,784 shares

    22.48% of the 13F portfolio, value $79,033,784.

    13F-HR 0001953107-26-000008 filed by ENAVATE SCIENCES GP, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 4,768,583 shares
    Change vs previous 13F 0 shares

    20.21% of the 13F portfolio, value $102,429,163.

    13F-HR 0001953107-26-000003 filed by ENAVATE SCIENCES GP, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 4,768,583 shares
    Change vs previous 13F 0 shares

    17.05% of the 13F portfolio, value $55,840,107.

    13F-HR 0001953107-25-000014 filed by ENAVATE SCIENCES GP, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 4,768,583 shares
    Change vs previous 13F 0 shares

    25.12% of the 13F portfolio, value $44,347,822.

    13F-HR 0001415889-25-021852 filed by ENAVATE SCIENCES GP, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2025-03-31
    13F 4,768,583 shares
    Change vs previous 13F +1,290,322 shares

    24.18% of the 13F portfolio, value $32,092,564.

    13F-HR 0001415889-25-013132 filed by ENAVATE SCIENCES GP, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2024-12-31
    13F 3,478,261 shares
    Change vs previous 13F not available

    26.53% of the 13F portfolio, value $36,939,132.

    13F-HR 0001104659-25-014094 filed by ENAVATE SCIENCES GP, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).